Pacemaker-mediated reentrant arrhythmia facilitated by an atrial-tracking leadless pacemaker.

J Cardiovasc Electrophysiol

Department of Medicine, Division of Cardiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.

Published: September 2024

AI Article Synopsis

  • Pacemaker-mediated tachycardia (PMRA) can occur in patients with dual chamber pacemakers and is particularly noted in those with intact ventriculoatrial conduction.
  • A 91-year-old female with new cardiomyopathy received an AV synchronous leadless pacemaker, which led to frequent atrial and ventricular pacing issues, identified as PMRA due to changes in heart rates.
  • The study highlights that PMRA may be overlooked in patients with leadless pacemakers, emphasizing the need for further research on its management and impact.

Article Abstract

Introduction: Pacemaker-mediated tachycardia is a known arrhythmia in patients with dual chamber pacemakers and defibrillators and intact ventriculoatrial (VA) conduction. We report a case of pacemaker-mediated reentrant arrhythmia (PMRA) in a patient with an atrioventricular (AV) synchronous leadless pacemaker.

Methods And Results: A 91-year-old female presented with 2:1 AV conduction and received an AV synchronous leadless pacemaker. She had atrial mechanical sense-ventricular paced beats between heart rates of 80-100 bpm more than 80% of the time. She was found to have a new cardiomyopathy and was referred for placement of biventricular pacemaker. At the time of device implantation, her electrocardiogram showed ventricular pacing with a short RP interval and superiorly directed P waves. Changes in the ventricular pacing rate resulted in changes in the atrial rate. Following device placement, her heart rate decreased to the lower rate limit of her pacemaker. The atrial mechanical sense impulse most likely was generated by a retrograde conducted P wave resulting in near incessant PMRA.

Conclusion: PMRA may occur in patients who receive an AV synchronous leadless pacemaker with intact VA conduction and sinoatrial node dysfunction. Due to the lower rates of PMRA, this arrhythmia may be underrecognized. Interventions for and implications of PMRA need further investigation.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jce.16350DOI Listing

Publication Analysis

Top Keywords

leadless pacemaker
12
synchronous leadless
12
pacemaker-mediated reentrant
8
reentrant arrhythmia
8
pacemaker atrial
8
atrial mechanical
8
ventricular pacing
8
pacemaker
5
arrhythmia
4
arrhythmia facilitated
4

Similar Publications

Background: The growing use of leadless pacemaker (LP) technology requires safe and effective solutions for retrieving and removing these devices over the long term.

Objectives: This study sought to evaluate retrieval and removal of an active helix-fixation LP studied in worldwide regulatory clinical trials.

Methods: Subjects enrolled in the LEADLESS II phase 1 investigational device exemption, LEADLESS Observational, or LEADLESS Japan trials with an attempted LP retrieval at least 6 weeks postimplantation were included.

View Article and Find Full Text PDF

A leadless pacemaker (LP) is a modern alternative to a transvenous pacemaker, allowing certain complications to be avoided; however, some cannot be eliminated. To highlight the essential role of advanced speckle-tracking echocardiography (STE) in diagnosing pacing-induced cardiomyopathy (PICM) caused by an LP. A 79-year-old male, after LP implantation a year earlier, was admitted due to heart failure (HF).

View Article and Find Full Text PDF

A 21-year-old man, known case of the repaired congenital heart disease, developed complete atrioventricular block (AVB) one week after simultaneous bioprosthetic pulmonary and tricuspid valve replacement and atrial septal defect repair. Considering the persistence of the AVB, it was decided to implant a permanent pacemaker. After considering all available options and the issues related to the patient, it was decided to implant a leadless pacemaker (LLP).

View Article and Find Full Text PDF

Background: To investigate the optimization of leadless pacemaker placement and to assess its impact on heart synchronization and tricuspid regurgitation.

Results: A clinical trial was conducted involving 53 patients who underwent leadless pacemaker implantation at the Second Affiliated Hospital of Zhejiang University School of Medicine and Hangzhou First People's Hospital between March 2022 and February 2023. Implantation site localization was determined using the 18-segment method under RAO 30° imaging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!